Key Highlights
- Adjusted distributable Earnings were USD 0.49 per share versus a USD 0.50 estimate; Revenue of USD 12.5 million trailed forecasts.
- The company paid a regular Dividend of USD 0.47 per share, its 18th consecutive quarterly payment.
- The Loan portfolio totaled USD 527.7 million across 28 companies at a weighted average Yield to Maturity of 14.8%.
- Non-accrual loans were about 3.1% of the portfolio, compared with roughly 3.7% at the end of June.
Chicago Atlantic Real Estate Finance (NASDAQ:REFI) reported third quarter 2026 adjusted distributable earnings of USD 0.49 per fully diluted share, a cent below the USD 0.50 estimate, on revenue of USD 12.5 million against a USD 14.95 million estimate. The company paid its regular quarterly dividend of USD 0.47 per share, the 18th consecutive quarter of doing so, and deployed more than USD 85 million of new principal fundings.
The company also added capacity to its revolving Credit Facility and completed the Koach transaction in July. It issued about 4.3 million new common shares at USD 14.535 per share in exchange for second Lien notes with an aggregate principal balance of USD 62.6 million. The notes contributed roughly USD 2.6 million to distributable earnings in the quarter, and management said they generated an annualized return above 18%, against a stated yield of about 12%.
Portfolio Quality and Yield
At September 30 the total principal balance of the loan portfolio, including loans held for investment, loans at Fair Value and the Koach notes, was approximately USD 527.7 million across 28 portfolio companies, with a weighted average yield to maturity of 14.8%. Management compared that with 6% to 8% on a comparable basis among selected commercial Mortgage REIT peers, and said the company operates at 0.48 times Debt to Equity compared with a peer range of about 3 times to 5 times.
Repayments were about USD 13.2 million: USD 3.8 million of scheduled amortization, USD 7.0 million of full prepayments and USD 2.4 million of partial prepayments. Credit quality was described as relatively consistent, with 89.3% of the portfolio risk rated 3 or below and 10.7% rated 4 or 5. Non-accruals were unchanged in dollar terms from June 30 and equaled approximately 3.1% of principal, compared with about 3.7% previously, with the decline attributed to portfolio growth.
The Balance Sheet shows a current expected credit Loss Reserve of USD 12.3 million at September 30, up from USD 5.1 million at December 31, 2025.
Rate Sensitivity and Regulatory Backdrop
Management said about 57% of the portfolio benefits from rising interest rates, and because the loans lack rate caps, each 25 basis point increase is projected to lift quarterly distributable earnings by about USD 0.015 per share. The Federal Reserve raised rates by 25 basis points on September 17, and the 10-year Treasury Yield rose about 54 basis points during September.
The quarterly filing also discusses a Department of Justice order, issued through the Drug Enforcement Administration, to reclassify certain cannabis products under the Controlled Substances Act from Schedule I to Schedule III, a development that bears on the borrowers the company finances.
Credit and Capital Factors to Watch
The company points to loan originations versus repayments, the trend in non-accruals and risk-rated 4 or 5 loans, and the size of the credit loss reserve as the main credit markers. Dividend coverage against adjusted distributable earnings is another, given the quarter's USD 0.49 against a USD 0.47 payout.
Regulatory developments on cannabis scheduling and the contribution of the Koach notes to yield are additional items to follow.






Please wait processing your request...